FindTrial
Sign In

Buprenorphine Maintenance Dose Schedule and Treatment Setting - 2

Buprenorphine Maintenance Dose Schedule and Treatment Setting

Status
Completed
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00000319
Enrollment
0
Registered
1999-09-21
Start date
1996-06-30
Completion date
2005-01-31
Last updated
2020-07-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Opioid-Related Disorders, Substance-Related Disorders

Keywords

Opioid-Related Disorders

Brief summary

The purpose of this study is to evaluate the efficacy of treating opioid-dependent individuals with buprenorphine on a thrice-weekly schedule compared to daily dosing.

Interventions

DRUGBuprenorphine

Sponsors

National Institute on Drug Abuse (NIDA)
CollaboratorNIH
Yale University
Lead SponsorOTHER

Study design

Primary purpose
TREATMENT

Eligibility

Sex/Gender
ALL
Age
21 Years to 55 Years
Healthy volunteers
No

Inclusion criteria

Please contact site for information.

Design outcomes

Primary

MeasureTime frame
Withdrawal symptoms—
Opioid and cocaine use—
Social and psychological functioning—
AIDS risk behavior—
Opiate withdrawal symptoms—
Depression—

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026